← Back to Dashboard

Odefsey

NNRTI + 2x NRTI

Constituent drugs (3)

Rilpivirine

Loading structure...
3D not available

Emtricitabine

Loading structure...
3D not available

Tenofovir Alafenamide

Loading structure...
3D not available

Chemical Identifiers

Clinical Development by Virus1

Human immunodeficiency virus 1
HIV-1
Target: Viral RT
Approved (other)
Preclinical
Phase 2positive
Phase 3positive
Approved
Japan
Approval ref (pmda.go.jp) PMDA approved Aug. 21, 2018fixed-dose combination of Rilpivirine, Emtricitabine, Tenofovir alafenamide.